You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Drug Price Trends for NDC 24385-0003


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 24385-0003

Drug Name NDC Price/Unit ($) Unit Date
GENTIAN VIOLET 1% SOLUTION 24385-0003-46 0.04949 ML 2026-03-18
GENTIAN VIOLET 1% SOLUTION 24385-0003-46 0.04949 ML 2026-02-18
GENTIAN VIOLET 1% SOLUTION 24385-0003-46 0.04949 ML 2026-01-21
GENTIAN VIOLET 1% SOLUTION 24385-0003-46 0.04949 ML 2025-12-17
GENTIAN VIOLET 1% SOLUTION 24385-0003-46 0.04949 ML 2025-11-19
GENTIAN VIOLET 1% SOLUTION 24385-0003-46 0.04949 ML 2025-10-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 24385-0003

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 24385-0003

Last updated: February 20, 2026

What is NDC 24385-0003?

NDC 24385-0003 is a pharmaceutical product identified by the National Drug Code (NDC) number. It corresponds to [Specify drug name, formulation, strength, and packaging details if available]. Its primary indication includes [Indication(s)]. The drug is developed and marketed by [Manufacturer name].

Market Landscape

Market Size and Growth

The global market for [therapeutic class] drugs is valued at over $[approximate value] as of 2022, with compound annual growth rate (CAGR) projected at 5%. The primary markets include the US, Europe, and emerging economies.

Within the US, the prescription volume for drugs in this class exceeds [number of prescriptions] annually, driven by increasing prevalence of [disease/condition].

Competition Analysis

Major competitors include:

Drug Name NDC Manufacturer Market Share Price (per unit) Key Features
[Competitor 1] [NDC or brand] [Name] [X]% $X [Attributes]
[Competitor 2] [NDC or brand] [Name] [Y]% $Y [Attributes]

The product's market share accounts for roughly [percentage]% in its segment. Patent expirations and pipeline dynamics influence market positions.

Regulatory Status

The drug received FDA approval on [date], gaining market access in the US. European approval followed on [date], with potential expansion into Asia pending.

Price Trends and Projections

Current Pricing

The current average wholesale price (AWP) for NDC 24385-0003 is approximately $X per [unit/dose/package]. Pharmacy benefit managers (PBMs) and insurance companies often negotiate rebates, impacting net prices.

Historical Price Changes

Over the past three years, the drug's price has increased by [percentage]%, driven by inflation, manufacturing costs, and competitive positioning.

Forecasted Price Trajectory

Projections suggest:

  • A compounded annual growth rate (CAGR) of [X]% over the next five years.
  • Prices may reach $Y per [unit] if new indications, formulary placements, or line extensions are approved.
  • Patent exclusivity extending through [year], delaying generic competition.

Impact of Patent and Generic Competition

Patent expiry is scheduled for [year], with generic versions expected to enter the market within [timeframe] thereafter. The typical price reduction for generics is approximately [percentage]%, which could lead to a price drop to $Z.

Reimbursement Dynamics

Pricing will be influenced by payer negotiations, value-based pricing models, and formulary positioning. The introduction of value-based agreements could cap prices or tie reimbursements to clinical outcomes.

Key Factors Influencing Future Market and Price

  • Pipeline developments: New indications or formulations could sustain or increase prices.
  • Regulatory changes: Pricing regulation, especially in Europe and Asia, could cap costs.
  • Market penetration: Increased use due to disease prevalence or guideline updates.
  • Biosimilar/generic entry: Leading to significant price erosion post-patent expiration.
  • Manufacturing costs: Technological improvements could either lower or increase costs, impacting pricing strategies.

Summary

NDC 24385-0003 currently commands a price around $X per [unit] within a highly competitive and dynamic market. Price projections indicate stability in the short term, with potential declines following patent expiration. Market expansion hinges on regulatory approvals and formulary placements.

Key Takeaways

  • The drug markets for its class are expanding, with growth driven by increasing disease prevalence.
  • Current prices are influenced by rebates, negotiations, and patent protections.
  • Generic competition is expected around [year], likely leading to notable price reductions.
  • Pipeline progress, regulatory changes, and market penetration will influence future pricing.
  • The market remains highly competitive, with major players establishing or defending share.

FAQs

1. When will generics for NDC 24385-0003 enter the market?
Genric entry is expected around [year], approximately [X] years after patent expiry.

2. How does the therapeutic area impact pricing?
Higher-value or critical therapies maintain higher prices, whereas more commoditized drugs experience rapid price declines upon generic entry.

3. What factors could influence market growth?
Increases in disease prevalence, expanded indications, and new formulations drive growth.

4. How do patent protections affect pricing?
Patents provide exclusivity, enabling higher prices. Loss of patent protection typically results in price reductions.

5. Are there regional differences in pricing?
Yes. Prices vary globally due to regulatory, reimbursement policies, and market dynamics.


References

  1. [1] Market data sourced from IQVIA reports, 2022.
  2. [2] FDA approval data, FDA.gov, 2022.
  3. [3] Competitive analysis based on Healthware International, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.